Author

H. Chen

Institution: Cidara Therapeutics (United States)

Observed institution: Cidara Therapeutics (United States)

ORCID: 0000-0002-7835-4314

Observed ORCID: 0000-0002-7835-4314

OpenAlex ID: A5017378964

153P Discovery of a novel, dual CD73 and PD-1 targeting multispecific drug Fc-conjugate (DFC) for the treatment of cancer

2023 · J. Levin, S. Döhrmann, et al. · Immuno-Oncology Technology · 1

144P Discovery of CBO421: A first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancer

2023 · S. Döhrmann, J. Levin, et al. · Immuno-Oncology Technology

45P Discovery of CBO-212, a first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancer

2023 · J. Levin, S. Döhrmann, et al. · ESMO Open

Works count: 3

Citation count: 1

H-index: 1

I10-index: